Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1966 | 1 |
2015 | 1 |
2023 | 4 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.
N Engl J Med. 2023 Nov 2;389(18):1672-1684. doi: 10.1056/NEJMoa2304875. Epub 2023 Oct 23.
N Engl J Med. 2023.
PMID: 37870974
Clinical Trial.
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial.
Saad F, Clarke NW, Oya M, Shore N, Procopio G, Guedes JD, Arslan C, Mehra N, Parnis F, Brown E, Schlürmann F, Joung JY, Sugimoto M, Sartor O, Liu YZ, Poehlein C, Barker L, Del Rosario PM, Armstrong AJ.
Saad F, et al. Among authors: guedes jd.
Lancet Oncol. 2023 Oct;24(10):1094-1108. doi: 10.1016/S1470-2045(23)00382-0. Epub 2023 Sep 12.
Lancet Oncol. 2023.
PMID: 37714168
Clinical Trial.
Item in Clipboard
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators.
Westin SN, et al.
J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21.
J Clin Oncol. 2024.
PMID: 37864337
Free PMC article.
Clinical Trial.
Item in Clipboard
Climate change fostered rise and fall of the Tibetan Empire during 600-800 AD.
Hou J, Ji K, Zhu E, Dong G, Tong T, Chu G, Liu W, Wu W, Zhang S, Guedes JD, Chen F.
Hou J, et al. Among authors: guedes jd.
Sci Bull (Beijing). 2023 Jun 15;68(11):1187-1194. doi: 10.1016/j.scib.2023.04.040. Epub 2023 May 2.
Sci Bull (Beijing). 2023.
PMID: 37179230
Item in Clipboard
Asian archaeology. Comment on "Agriculture facilitated permanent human occupation of the Tibetan Plateau after 3600 B.P. ".
Guedes Jd, Bocinsky RK, Butler EE.
Guedes Jd, et al.
Science. 2015 May 22;348(6237):872. doi: 10.1126/science.aaa4819.
Science. 2015.
PMID: 25999499
Item in Clipboard
[Immunity to diphtheria studied with the Schick test and determination of circulating diphtheria antitoxin].
Guedes JD, Cotillo LG, Iaria ST, Santos JA, Bourroul GP.
Guedes JD, et al.
Arq Fac Hig Saude Publica Univ Sao Paulo. 1966 Dec;20(2):233-40.
Arq Fac Hig Saude Publica Univ Sao Paulo. 1966.
PMID: 5994236
Portuguese.
No abstract available.
Item in Clipboard
Cite
Cite